Merck (MRK) Other Non Operating Income (2009 - 2026)

Merck (MRK) has 18 years of Other Non Operating Income data on file, last reported at -$138.0 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$138.0 million, down 494.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$325.0 million (down 1260.71% YoY), and the FY2025 annual result was -$151.0 million, down 729.17% from the prior year.
• Other Non Operating Income rose to -$138.0 million in Q1 2026 per MRK's latest filing, from -$432.0 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $238.0 million in Q3 2025 and troughed at -$708.0 million in Q1 2022.
• A 5-year average of -$131.1 million and a median of -$89.0 million in 2023 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2024: Other Non Operating Income sank 525.24% in 2022, then jumped 228.57% in 2024.
• A 5-year view of Other Non Operating Income shows it stood at $75.0 million in 2022, then sank by 204.0% to -$78.0 million in 2023, then slumped by 62.82% to -$127.0 million in 2024, then slumped by 240.16% to -$432.0 million in 2025, then soared by 68.06% to -$138.0 million in 2026.
• Business Quant data shows MRK's Other Non Operating Income at -$138.0 million in Q1 2026, -$432.0 million in Q4 2025, and $238.0 million in Q3 2025.